South Korean AI firm Lunit has expanded its partnership with Saudi Arabia's HMG to deploy its INSIGHT CXR AI solution for medical imaging. This move deepens Lunit's presence in the Middle East healthcare market, validating its technology and positioning it for future revenue growth.
This expanded partnership with a major Saudi medical group provides Lunit with a strong foothold in the lucrative and growing Middle Eastern healthcare market. It serves as a powerful validation of their AI-powered cancer screening technology and a strategic springboard for further expansion across the region, potentially unlocking access to a large patient population and driving future revenue growth.
Expands partnership with Saudi Arabia's HMG to deploy Lunit INSIGHT CXR
Reports 2024 revenue of KRW 54.2 billion, a 2.2x YoY increase
Secures role in UAE's national breast cancer screening program
Secures role in UAE's national breast cancer screening program
Gains regulatory approval for products in Bangladesh
Sign in to save notes on signals.
Sign In